Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03505003
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
AAY | 8-[2-((2S)-4-HYDROXY-1-{[5-(HYDROXYMETHYL)- 6-METHOXY-2-NAPHTHYL]METHYL}-6- OXOPIPERIDIN-2-YL)ETHYL]-3,7-DIMETHYL- 1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN- 1-YL 2-METHYLBUTANOATE | A,B | 1XDD | 0.7 |  |
FBR | (9aS)-4-bromo-9a-butyl-7-hydroxy- 1,2,9,9a-tetrahydro-3H-fluoren- 3-one | A | 2GIU | 0.72 | |
ETC | (R,R)-5,11-CIS-DIETHYL-5,6,11,12- TETRAHYDROCHRYSENE-2,8-DIOL | A,B | 1L2I | 0.7 | |
| ETC | (R,R)-5,11-CIS-DIETHYL-5,6,11,12- TETRAHYDROCHRYSENE-2,8-DIOL | A,B | 1L2J | 0.7 | |
17M | 17-METHYL-17-ALPHA-DIHYDROEQUILENIN | A,B | 2B1Z | 0.71 | |
EST | ESTRADIOL | A,B | 1GWR | 0.72 | |
| EST | ESTRADIOL | A | 1FDS | 0.72 | |
| EST | ESTRADIOL | A,B,C | 1G50 | 0.72 | |
| EST | ESTRADIOL | A,B,C,D,E,F | 1ERE | 0.72 | |
| EST | ESTRADIOL | A,B | 1A52 | 0.72 | |
| EST | ESTRADIOL | A | 1FDT | 0.72 | |
| EST | ESTRADIOL | A | 2OCF | 0.72 | |
| EST | ESTRADIOL | A,B,C | 1QKU | 0.72 | |
| EST | ESTRADIOL | A,B,C,D,L | 1E6W | 0.72 | |
| EST | ESTRADIOL | A | 1IOL | 0.72 | |
| EST | ESTRADIOL | H | 1JNN | 0.72 | |
| EST | ESTRADIOL | B | 1QKT | 0.72 | |
| EST | ESTRADIOL | A | 1FDW | 0.72 | |
| EST | ESTRADIOL | A,B | 1AQU | 0.72 | |
| EST | ESTRADIOL | A | 1LHU | 0.72 | |
| EST | ESTRADIOL | A | 1A27 | 0.72 | |
| EST | ESTRADIOL | L | 1JGL | 0.72 | |
| EST | ESTRADIOL | A,B,E,F | 1PCG | 0.72 | |
| EST | ESTRADIOL | A,B,C,D | 1FDU | 0.72 | |
| EST | ESTRADIOL | A | 2J7X | 0.72 | |
| EST | ESTRADIOL | A,B | 2D06 | 0.72 | |
DTY | D-TYROSINE | A | 1C4B | 0.71 | |
| DTY | D-TYROSINE | A,L | 1ZEA | 0.71 | |
| DTY | D-TYROSINE | A,B,C,D,E,F, G,H | 1OF6 | 0.71 | |
| DTY | D-TYROSINE | A,B | 1UNO | 0.71 | |
| DTY | D-TYROSINE | A | 2IGZ | 0.71 | |
| DTY | D-TYROSINE | A,B,C,H,K,L | 2R5D | 0.71 | |
| DTY | D-TYROSINE | A,B | 2Q33 | 0.71 | |
| DTY | D-TYROSINE | H,S | 2H9E | 0.71 | |
| DTY | D-TYROSINE | A,B,C,H,K,L | 2R5B | 0.71 | |
| DTY | D-TYROSINE | A | 2IH0 | 0.71 | |
| DTY | D-TYROSINE | A | 1D7T | 0.71 | |
| DTY | D-TYROSINE | A,B | 1XA0 | 0.71 | |
TYB | TYROSINAL | A,B | 1KDZ | 0.71 | |
| TYB | TYROSINAL | A | 1Q11 | 0.71 | |
| TYB | TYROSINAL | A,B | 2J5B | 0.71 | |
| TYB | TYROSINAL | A,I | 1GA4 | 0.71 | |
| TYB | TYROSINAL | A,B,C | 1NLU | 0.71 | |
| TYB | TYROSINAL | A,B | 1KE1 | 0.71 | |
| TYB | TYROSINAL | A,B | 1H3F | 0.71 | |
| TYB | TYROSINAL | A,B | 1H3E | 0.71 | |
SDT | 3,4-dihydroxy-9,10-secoandrosta- 1(10),2,4-triene-9,17-dione | A,B | 2ZI8 | 0.74 | |
ESL | ESTRIOL | A | 1X8V | 0.71 | |
E3O | (16ALPHA,17ALPHA)-ESTRA-1,3,5(10)- TRIENE-3,16,17-TRIOL | A | 2J7Y | 0.71 | |
EED | (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)- 11-(METHOXYMETHYL)ESTRA-1(10),2,4- TRIENE-3,17-DIOL | A,B | 2QGT | 0.7 | |
MTY | META-TYROSINE | A | 2TOH | 0.7 | |
| MTY | META-TYROSINE | A,B | 1BIQ | 0.7 | |
| MTY | META-TYROSINE | A | 1Q7O | 0.7 | |
SAF | 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL | A | 1GQR | 0.71 | |
| SAF | 3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL | A | 1GQS | 0.71 | |
MUF | (8alpha,10alpha,13alpha,17beta)- 17-[(4-hydroxyphenyl)carbonyl]androsta- 3,5-diene-3-carboxylic acid | A,B | 3BEJ | 0.71 | |
EZT | (17BETA)-17-{(E)-2-[2-(TRIFLUOROMETHYL)PHENYL]VINYL}ESTRA- 1(10),2,4-TRIENE-3,17-DIOL | A,B | 2P15 | 0.7 | |
TYP | CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR | A,B | 1W1Y | 0.73 | |
099 | (2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)- N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro- 1H-inden-1-yl]butanediamide | A,B | 3HYG | 0.7 | |
EQU | EQUILENIN | A,B | 1OGX | 0.78 | |
| EQU | EQUILENIN | A,B,C,D,E,F | 1QJG | 0.78 | |
| EQU | EQUILENIN | A,B | 1OH0 | 0.78 | |
| EQU | EQUILENIN | A | 1W6Y | 0.78 | |
| EQU | EQUILENIN | A,B | 1CQS | 0.78 | |
| EQU | EQUILENIN | A | 1OGZ | 0.78 | |
| EQU | EQUILENIN | A | 1GS3 | 0.78 | |
| EQU | EQUILENIN | A | 1OHO | 0.78 | |
TYC | L-TYROSINAMIDE | A | 2BF9 | 0.71 | |
| TYC | L-TYROSINAMIDE | A | 2OCI | 0.71 | |
MOI | (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A- HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2- E]ISOQUINOLINE-7,9-DIOL | H,L | 1Q0Y | 0.7 | |
NLT | N-DODECANOYL-L-TYROSINE | A,B,C,D,E,F, G,H | 2G0B | 0.72 | |
BM4 | 3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl- 3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan- 3-yl]phenol | X | 2W6C | 0.74 | |
HE7 | 4-{[(14beta,17alpha)-3-hydroxyestra- 1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid | A,B,C,D | 2Z77 | 0.71 | |
YTT | (3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine- 2,5-dione | A | 3G5H | 0.75 | |
LOB | LOBELINE | A,B,C,D,E,F, G,H,I,J | 2BYS | 0.72 | |
AOE | N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)- 3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17- DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN- 7-YL]-N-METHYLUNDECANAMIDE | A | 1HJ1 | 0.84 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 3HF0 | 0.71 | |
| B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 2OXK | 0.71 | |
| B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A,B,C | 2OXJ | 0.71 | |
NLX | (5A,17R)-4,5-EPOXY-3,14-DIHYDROXY- 17-METHYL-6-OXO-17-(2-PROPENYL)- MORPHINANIUM | A,B,C,D,E,F, G,H,I,J,K,L | 1MX9 | 0.71 | |
TNC | 4-DIMETHYLAMINO-1,10,11,12-TETRAHYDROXY- 3-OXO-3,4,4A,5-TETRAHYDRO-NAPHTHACENE- 2-CARBOXYLIC ACID AMIDE | A,B | 1N5Q | 0.71 | |
DRQ | (9ALPHA,13BETA,17BETA)-2-[(1Z)- BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE- 3,17-DIOL | A,B | 2G5O | 0.71 | |
ESO | O3-PHOSPHONOESTRONE | B,C | 1ESS | 0.74 | |
MA0 | (1R)-6-HYDROXY-N-METHYL-N-[(1Z)- PROP-2-EN-1-YLIDENE]INDAN-1-AMINIUM | A,B | 2C64 | 0.71 | |
E20 | 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON- 2-YL)METHYL]PIPERIDINE | A | 1EVE | 0.71 | |
3QC | (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8- TETRAMETHYL-3,4-DIHYDROISOQUINOLINE- 2(1H)-CARBOXAMIDE | A,B | 2FME | 0.73 | |
EQI | EQUILIN | A,B | 1EQU | 0.79 | |